Recent Business Highlights

Aurigene: Specialized Biotech division focused on addressing critical needs in Oncology and Auto-immune therapeutic areas BUSINESS MODEL Focused on Oncology & inflammation disorders Complementing infrastructure for small molecule & peptide drug discovery Client value proposition characterized by collaboration & licensing Multi-year collaborations with 6 of top-10 pharmaceutical companies OUTCOMES 70+ integrated discovery programs resulting in over 135 patents in the last 10 years Out-licensed multiple early-stage and late stage programs 11 INDs filed under collaboration programs; multiple assets in Phase I/II Pipeline of programs in Immuno-oncology, Epigenetics & Th17 pathway 23

View entire presentation